Skip to content
    Alta Partners logo

    Alta Partners

    San Francisco, California, United StatesFounded 1996
    www.altapartners.comLinkedIn
    Biotech & Life SciencesHealthcare

    Alta Partners is a leading healthcare and life sciences venture capital firm based in San Francisco, founded in 1996. The firm invests in early-stage curative therapeutics and technology-enabled healthcare services through its family of NextGen funds.

    Average disclosed round size is $49.6M (across 128 rounds with reported amounts).

    Find people at Alta Partners on Goldilocks AI

    Portfolio

    91

    Fund Size

    $275M

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    BM

    Bob More

    Managing Director

    DJ

    Dan Janney

    Managing Director

    LR

    Larry Randall

    Chief Financial Officer

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    136 investments
    CompanyRoundAmountDate
    eGenesis logoeGenesisSeries D$191MAug 2025
    Portola logoPortolaSeries A—Jul 2025
    Insulet logoInsuletUnknown$50MJan 2025
    Sedgwick logoSedgwickUnknown—Nov 2024
    Progentos Therapeutics logoProgentos TherapeuticsSeries A$65MMay 2024
    Transcarent logoTranscarentSeries D$126MMay 2024
    Harbor Health logoHarbor HealthSeries C$95.5MJan 2024
    Transcarent logoTranscarentSeries D$126MJan 2024
    eGenesis logoeGenesisSeries B$100MJan 2024
    MBrace logoMBraceSeries A$85MNov 2023
    MBrace Therapeutics logoMBrace TherapeuticsSeries A$85MNov 2023
    Free Market Health logoFree Market HealthSeries A$20MNov 2023
    Lassen Therapeutics logoLassen TherapeuticsSeries B$85MJan 2023
    MBrace Therapeutics logoMBrace TherapeuticsSeries B$85MJan 2023
    MBrace logoMBraceSeries B$85MJan 2023
    EEverside HealthGrowth$164MJul 2022
    EEversideGrowth$164MJul 2022
    DEM Biopharma logoDEM BiopharmaUnknown$70MJun 2022
    Angel Studios logoAngel StudiosSeries B$47MJan 2022
    Transcarent logoTranscarentSeries C—Jan 2022
    Novome Biotechnologies logoNovome BiotechnologiesSeries B—Jan 2022
    Transcarent logoTranscarentSeries B$58MJun 2021
    TYRA Biosciences logoTYRA BiosciencesSeries B$106MMar 2021
    Tyra logoTyraSeries B$106MMar 2021
    DispatchHealth logoDispatchHealthSeries D$200MMar 2021
    Page 1 of 6

    Top Co-Investors

    Amgen Ventures13 shared
    New Enterprise Associates12 shared
    Venrock10 shared
    Frazier Healthcare Partners8 shared
    General Catalyst7 shared
    Canaan Partners7 shared
    ARCH Venture Partners7 shared
    Pivotal Life Sciences7 shared
    RiverVest Venture Partners7 shared
    Leaps by Bayer7 shared
    Celgene7 shared
    SV Health Investors7 shared
    Samsara BioCapital7 shared
    Alexandria Venture Investments7 shared
    Gimv7 shared
    Khosla Ventures7 shared
    InterWest Partners6 shared
    Tekla Capital Management6 shared
    Polaris Partners6 shared
    Sofinnova Partners6 shared

    Last updated: 20 October 2026